Literature DB >> 22696641

Biochemical analysis of the complex between the tetrameric export adapter protein Rec of HERV-K/HML-2 and the responsive RNA element RcRE pck30.

Janina S Langner1, Nina V Fuchs, Jan Hoffmann, Alexander Wittmann, Bernhard Brutschy, Roswitha Löwer, Beatrix Suess.   

Abstract

The RNA export adaptor protein Rec, encoded for by the human endogenous retrovirus HERV-K/HML-2 elements, binds to the Rec responsive element (RcRE) located in the 3' untranslated region of HERV-K/HML-2 transcripts. Binding allows the nucleocytoplasmic export of unspliced viral RNA, thereby overcoming host restriction. Chemical probing of the secondary structure of the RcRE corroborated the theory that the RcRE forms a complex folded structure with seven stem-loop regions. Laser-induced liquid beam ion desorption mass spectrometry revealed that Rec forms stable tetramers, which are further stabilized upon RNA binding. The RNA protein complex consists of three Rec tetramers, which bind to multiple sites on the RcRE-preferentially to purine-rich motifs-which represent several low-affinity binding sites. Mutated RcREs, with one to three purine-rich motifs deleted, were still bound and exported by Rec, indicating that the complex folded structure of the RcRE is important for Rec binding. This suggests a binding model where up to three Rec tetramers bind to the complex folded structure of the RcRE and the binding seems to be tightened by recognition of the purine-rich motifs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22696641      PMCID: PMC3416163          DOI: 10.1128/JVI.00121-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Characterization of HIV-1 REV protein: binding stoichiometry and minimal RNA substrate.

Authors:  K S Cook; G J Fisk; J Hauber; N Usman; T J Daly; J R Rusche
Journal:  Nucleic Acids Res       Date:  1991-04-11       Impact factor: 16.971

2.  Transcriptional (p40x) and post-transcriptional (p27x-III) regulators are required for the expression and replication of human T-cell leukemia virus type I genes.

Authors:  J Inoue; M Yoshida; M Seiki
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

3.  rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA.

Authors:  B K Felber; M Hadzopoulou-Cladaras; C Cladaras; T Copeland; G N Pavlakis
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

4.  The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA.

Authors:  M H Malim; J Hauber; S Y Le; J V Maizel; B R Cullen
Journal:  Nature       Date:  1989-03-16       Impact factor: 49.962

5.  HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence.

Authors:  M H Malim; L S Tiley; D F McCarn; J R Rusche; J Hauber; B R Cullen
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

6.  Association of the pX gene product of human T-cell leukemia virus type-I with nucleus.

Authors:  T Kiyokawa; T Kawaguchi; M Seiki; M Yoshida
Journal:  Virology       Date:  1985-12       Impact factor: 3.616

Review 7.  The role of human endogenous retroviruses in melanoma.

Authors:  S Singh; S Kaye; M E Gore; M O McClure; C B Bunker
Journal:  Br J Dermatol       Date:  2009-07-20       Impact factor: 9.302

Review 8.  Retroelements and the human genome: new perspectives on an old relation.

Authors:  Norbert Bannert; Reinhard Kurth
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-13       Impact factor: 11.205

9.  Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1.

Authors:  S Schwartz; B K Felber; D M Benko; E M Fenyö; G N Pavlakis
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

10.  Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro.

Authors:  T J Daly; K S Cook; G S Gray; T E Maione; J R Rusche
Journal:  Nature       Date:  1989-12-14       Impact factor: 49.962

View more
  7 in total

Review 1.  A structurally plastic ribonucleoprotein complex mediates post-transcriptional gene regulation in HIV-1.

Authors:  Jason D Fernandes; David S Booth; Alan D Frankel
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-03-01       Impact factor: 9.957

2.  HIV-1 Rev interacts with HERV-K RcREs present in the human genome and promotes export of unspliced HERV-K proviral RNA.

Authors:  Laurie R Gray; Rachel E Jackson; Patrick E H Jackson; Stefan Bekiranov; David Rekosh; Marie-Louise Hammarskjöld
Journal:  Retrovirology       Date:  2019-12-16       Impact factor: 4.602

Review 3.  Human endogenous retrovirus-K (HML-2): a comprehensive review.

Authors:  Marta Garcia-Montojo; Tara Doucet-O'Hare; Lisa Henderson; Avindra Nath
Journal:  Crit Rev Microbiol       Date:  2018-10-14       Impact factor: 7.624

4.  Structural Mimicry Drives HIV-1 Rev-Mediated HERV-K Expression.

Authors:  Ina P O'Carroll; Lixin Fan; Tomáš Kroupa; Erin K McShane; Christophe Theodore; Elizabeth A Yates; Benjamin Kondrup; Jienyu Ding; Tyler S Martin; Alan Rein; Yun-Xing Wang
Journal:  J Mol Biol       Date:  2020-11-14       Impact factor: 5.469

5.  Staufen-1 interacts with the human endogenous retrovirus family HERV-K(HML-2) rec and gag proteins and increases virion production.

Authors:  Kirsten Hanke; Oliver Hohn; Linda Liedgens; Katharina Fiddeke; Jula Wamara; Reinhard Kurth; Norbert Bannert
Journal:  J Virol       Date:  2013-08-07       Impact factor: 5.103

Review 6.  Ancient Adversary - HERV-K (HML-2) in Cancer.

Authors:  Eoin Dervan; Dibyangana D Bhattacharyya; Jake D McAuliffe; Faizan H Khan; Sharon A Glynn
Journal:  Front Oncol       Date:  2021-05-13       Impact factor: 6.244

7.  Human Endogenous Retrovirus K Rec forms a Regulatory Loop with MITF that Opposes the Progression of Melanoma to an Invasive Stage.

Authors:  Manvendra Singh; Huiqiang Cai; Mario Bunse; Cédric Feschotte; Zsuzsanna Izsvák
Journal:  Viruses       Date:  2020-11-13       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.